The objectives of the study is to determine the efficacy, safety and performance of the MFM and its delivery system in patients at high surgical risk presenting with a type II, III thoracoabdominal aneurysm, below the left subclavian and above the iliac bifurcation, according to the Crawford classification.

hostile abdomen, including presence of ascites or other signs of portal hypertension;

obesity.

adequate arterial anatomy of aneurismal lesion access.

Exclusion Criteria:

medical contraindications to a local or general anesthesia and angiography;

Life expectancy less than one year, or clinical follow-up impossible;

congenital disorders of blood coagulation;

intercurrent infection;

allergy to aspirin, clopidogrel, or contrast agents;

patient(s) included in another clinical study;

patient pregnant or breastfeeding

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01756911